This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Hangzhou Tianlong Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Innovations of Inventor Kai Dong
Introduction
Kai Dong is a notable inventor based in Zhejiang, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of nucleic acid technologies. His work focuses on enhancing the stability and efficiency of mRNA, which is crucial for various applications in biotechnology and medicine.
Latest Patents
One of Kai Dong's key patents is titled "C6'-substituted locked nucleic acid-modified cap analog and use thereof." This patent presents a novel cap analog that improves the stability of mRNA and enhances its translation efficiency. The innovation holds promise for advancing mRNA-based therapies and vaccines.
Career Highlights
Kai Dong is currently employed at Hangzhou Tianlong Pharmaceutical Co., Ltd. His role at the company allows him to apply his expertise in nucleic acid modifications to develop cutting-edge pharmaceutical products. His contributions have been instrumental in the company's research and development efforts.
Collaborations
Kai Dong collaborates with talented colleagues, including Honglei Zhang and Yanfen Li. Together, they work on various projects aimed at improving mRNA technology and its applications in medicine.
Conclusion
In summary, Kai Dong is a pioneering inventor whose work in nucleic acid technology is making a significant impact in the pharmaceutical industry. His innovative patent and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile